- Analytica Investor
- Posts
- 📊 Biotech Holds Modest Gains
📊 Biotech Holds Modest Gains
Positive Phase 2 feedback ignites sharp move in neuro-focused biotech

Good Morning Investors,
The Dow Jones U.S. Semiconductors Index rose (+0.3%) in response to AI spending and China deal fueling growth advancements. NASDAQ Biotechnology also nudged up (+0.2%) despite Options Traders appearing to underplay the small-cap rally.
July's surge in wholesale inflation has slowed the stock surge and slight doubts are cast on the possibility of a rate cut with a higher bar from Fed. With PPI data sending stocks lower, experts are considering if the Fed could cut half a point in September.
Trump's pick for the next Fed chair, a decision believed to have potential market impact, is eagerly anticipated.
Matthias Schneider
Editor at Analytica Investor